Table 1 Different definitions and their cut-offs used to define the metabolic syndrome
World Health Organization (WHO) | European Group for the study of Insulin Resistance (EGIR) | American Association of Clinical Endocrinology (AACE) | |
|---|---|---|---|
Absolutely required | IGTa or IFGb or IRc or diabetes | Plasma insulin > 75 percentile of persons without diabetes in the population under study. | High risk of being insulin resistant d (excluding diabetes) |
Criteria | plus two or more of the below abnormalities | plus two or more of the four below abnormalities | Plus two or more of the four below abnormalities |
Adiposity index | WHR > 0.90 in men and >0.85 in women and/or BMI > 30 kg/m2 | WC ≥ 94 cm in men and ≥80 cm in women | none |
Triglycerides | ≥1.7 mmol/L and/or | >2 mmol/L and/or | >1.7 mmol/L |
HDL | <0.9 mmol/L in men and <1.0 mmol/L in women | <1.0 mmol/L or treated for dyslipidemia | <1.0 mmol/L in men and <1.3 mmol/L in women. |
Blood pressure | ≥140/90 mmHg or treated for hypertension | ≥140/90 mmHg or treated for hypertension | ≥130/85 mmHg or treated for hypertension |
Hyperglycemia | none | Fasting plasma glocuse ≥ 6.1 mmol/L (but without diabetes) | Fasting plasma glucose 6.1–6.9 mmol/L or IGT |